• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Stephen Gandel

Stay informed with Stephen Gandel’s coverage and analysis.

J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Here’s Why Valeant CEO Michael Pearson’s Stock Sale Matters
By Stephen GandelNovember 6, 2015
JPMorgan Chase & Co. Chief Executive Officer Jamie Dimon Interview
Finance
Jamie Dimon: Don’t be so Damned Depressed
By Stephen GandelNovember 4, 2015
Fortune Global Forum 2015
Finance
Jamie Dimon: Virtual Currency Will Be Stopped
By Stephen GandelNovember 4, 2015
Fortune Global Forum 2015
Finance
What Bank Accounts and Toilets Can Teach Us About Corruption in India
By Stephen GandelNovember 4, 2015
Satya Nadella Launches Microsoft Build Conference
Finance
Bond Market Rally: It’s Not Time for Economic Celebration Just Yet
By Stephen GandelNovember 2, 2015
Chart: Here’s what the U.S.’s largest companies are doing with their cash
Finance
Chart: Here’s what the U.S.’s largest companies are doing with their cash
By Stephen GandelOctober 31, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
Health
Valeant: A timeline of the big Pharma scandal
By Stephen GandelOctober 31, 2015
Hedge fund manager Bill Ackman
Finance
Bill Ackman on Valeant: ‘Life will go on’
By Stephen GandelOctober 30, 2015
Pfizer And AstraZeneca's Billion Dollar Battle
Finance
Pfizer-Allergan could be a super inversion deal
By Stephen GandelOctober 29, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Valeant accounting scandal: 4 critical questions that have been left unanswered
By Stephen GandelOctober 26, 2015
Hedge fund manager Bill Ackman
Finance
What the drop in Valeant’s stock says about hedge funds’ herd mentality
By Stephen GandelOctober 25, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Valeant short seller on pharmacy alliance: It’s the ‘turd in the punch bowl’
By Stephen GandelOctober 22, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance
Valeant’s accounting problems: It gets worse
By Stephen GandelOctober 22, 2015
Warren Buffett’s really bad week
Finance
Warren Buffett’s really bad week
By Stephen GandelOctober 22, 2015
Fortress Circling Stuyvesant Town Brings Sale Closer
Finance
What the $5 billion Stuyvesant Town deal says about the real estate market
By Stephen GandelOctober 20, 2015
1...
  • 21
  • 22
  • 23
  • 24
  • 25
...78
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.